Contract facts
FederalNo full NAICS 325412 intel page yet. Browse NAICS intelligence
Drugs and Biologicals is a federal award for 244-Network Contract Office 4 (36C244) held by Nuclear Diagnostic Products of Philadelphia, Inc. Estimated value $1.2M ($1.2M obligated). Current period of performance ends Nov 3, 2026. Place of performance: PHILADELPHIA PA.
Drugs and Biologicals. Latest action is a modification.
Recompete timing
PublicCurrent PoP ends Nov 3, 2026 (17 days remaining). Agencies typically plan 12–18 months ahead — at 0.6 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on 36C24426N0108? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordNuclear Diagnostic Products of Philadelphia, Inc — $6.3M obligated across 23 awards (firm-wide, all agencies).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C24426N0108?
36C24426N0108 (Drugs and biologicals) is a 244-Network Contract Office 4 (36C244) award with a potential value of $1.2M, currently held by Nuclear Diagnostic Products of Philadelphia, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C244-26-N-0108?
36C244-26-N-0108 is the dashed form of PIID 36C24426N0108 (Drugs and biologicals), held by Nuclear Diagnostic Products of Philadelphia, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C24426N0108?
244-Network Contract Office 4 (36C244) awarded 36C24426N0108 to Nuclear Diagnostic Products of Philadelphia, Inc (potential $1.2M).
Who is the incumbent on 36C24426N0108?
Nuclear Diagnostic Products of Philadelphia, Inc is the incumbent with $6.3M across 23 related awards in SCOUT’s public footprint. The current period of performance ends Nov 3, 2026.
When does Nuclear Diagnostic Products of Philadelphia, Inc’s 36C24426N0108 come up for recompete?
SCOUT tracks a period-of-performance end of Nov 3, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 36C24426N0108? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.